Free Cash Flow (Quarterly) Chart

View Free Cash Flow (Quarterly) for GH.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow (Quarterly) Chart
Start Trial

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -69.54M
March 31, 2026 -71.30M
December 31, 2025 -41.93M
September 30, 2025 -45.76M
June 30, 2025 -66.08M
March 31, 2025 -79.29M
December 31, 2024 -83.39M
September 30, 2024 -55.26M
June 30, 2024 -99.08M
March 31, 2024 -37.22M
December 31, 2023 -82.80M
September 30, 2023 -80.16M
June 30, 2023 -100.53M
March 31, 2023 -81.96M
December 31, 2022 -100.75M
September 30, 2022 -99.89M
Date Value
June 30, 2022 -134.97M
March 31, 2022 -51.32M
December 31, 2021 -101.61M
September 30, 2021 -75.29M
June 30, 2021 -81.27M
March 31, 2021 -25.88M
December 31, 2020 -66.50M
September 30, 2020 -17.84M
June 30, 2020 -32.87M
March 31, 2020 -40.77M
December 31, 2019 -37.43M
September 30, 2019 -7.097M
June 30, 2019 -16.88M
March 31, 2019 -7.008M
December 31, 2018 -29.47M
September 30, 2018 -27.96M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

View Free Cash Flow (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow (Quarterly) Benchmarks

View Free Cash Flow (Quarterly) Benchmarks
Start Trial
Natera, Inc. -8.636M
NeoGenomics, Inc. 11.74M
Quest Diagnostics, Inc. 459.00M
Labcorp Holdings, Inc. 313.90M
OPKO Health, Inc. -46.50M